Renovion Announces Completion of $8.1 Million Financing Round Enabling Clinical Programs in Chronic Inflammatory Lung Diseases
News published by Renovion, Inc. concerning their lead therapeutic candidate ARINA-1, administered via an optimized eFlow® Technology nebulizer.